Using the epidermal growth factor receptor as a biomarker, a gold-nanorods-based SERS tool that can identify and image the spatial and temporal distribution of breast cancer cells was developed by Xiao et al. [145]. This evidence concerns the gene EGFR and breast carcinoma.